RB
Robert Bruce (Bruce & Co) disclosed increased in XEL Energy
Robert Bruce (Bruce & Co) filed a 13F change in XEL Energy (98389B100) on 2024-11-14, covering period end 2024-09-30.
Action
Increased
Capital
$12,798,800 current disclosed value
Institutional 13F Signals1 evidence source
Why it matters
This signal is selected by portfolio impact within the manager filing, while the full filing change list remains available in the briefing.
Full Filing Changes
40 changes from Robert Bruce (Bruce & Co), filed 2024-11-14 for period end 2024-09-30.
$343.6M portfolio value
| Stock | Action | Change | Current | Portfolio Impact |
|---|---|---|---|---|
N00985106 AerCap Holdings | New | $7.6M | $7.6M | 2.21% |
302571104 Nextera Energy | Increased | $4.6M | $28.2M | 1.33% |
23586506 Uhaul B | Increased | $4.0M | $36.5M | 1.15% |
20002101 Allstate | Increased | $3.9M | $24.7M | 1.14% |
589331107 Merck | Reduced | -$3.4M | $24.4M | 1.00% |
00484MAB2 Acorda Theraputics | Reduced | -$3.3M | $200,000 | 0.96% |
39483102 Archer Daniels | Increased | $3.0M | $6.0M | 0.86% |
125896100 CMS Energy | Increased | $2.8M | $21.9M | 0.83% |
00206R102 AT & T | Increased | $2.8M | $21.6M | 0.83% |
H11356104 Bunge | Increased | $2.4M | $7.7M | 0.70% |
98389B100 XEL Energy | Increased | $2.3M | $12.8M | 0.68% |
237266101 Darling Ingredients | Increased | $2.0M | $7.5M | 0.57% |
26441C204 Duke Energy | Increased | $1.9M | $22.6M | 0.57% |
268311107 EDAP | Reduced | -$1.6M | $1.4M | 0.47% |
2824100 Abbott | Increased | $1.5M | $17.4M | 0.45% |
71535D106 Personalis | Increased | $1.3M | $1.6M | 0.37% |
00287Y109 Abbvie | Increased | $1.2M | $28.9M | 0.36% |
23586100 Uhaul | Increased | $1.2M | $5.8M | 0.34% |
651639106 Newmont | Increased | $1.2M | $5.3M | 0.34% |
449585108 IGM Bioscience | Increased | $967,000 | $1.7M | 0.28% |
37833100 Apple | Increased | $888,486 | $9.3M | 0.26% |
05379B107 Avista | Increased | $834,210 | $7.8M | 0.24% |
925815102 Vicor | Increased | $625,800 | $2.9M | 0.18% |
868459108 Supernus | Increased | $363,725 | $2.6M | 0.11% |
749607107 RLI | Increased | $320,096 | $3.5M | 0.09% |
717081103 Pfizer | Increased | $265,344 | $8.0M | 0.08% |
82968B103 XM Sirius | Reduced | -$259,404 | $1.3M | 0.08% |
31189P102 Fate Theraputics | Increased | $241,000 | $1.2M | 0.07% |
56400P706 Mannkind | Increased | $202,438 | $1.2M | 0.06% |
91911K102 Bausch Health | Reduced | -$161,500 | $3.7M | 0.05% |
65443P102 908 Devices | Reduced | -$114,721 | $236,952 | 0.03% |
44209104 Ashland | Reduced | -$112,800 | $1.3M | 0.03% |
50015M109 Kodiak Sciences | Increased | $109,980 | $1.1M | 0.03% |
N51517105 Lava Theraputics | Reduced | -$108,062 | $1.3M | 0.03% |
142038108 Caribou Biosciences | Increased | $96,000 | $588,000 | 0.03% |
92939U106 WEC Energy | Increased | $79,900 | $433,676 | 0.02% |
92556V106 Viatris | Increased | $57,656 | $683,051 | 0.02% |
68622V106 Organon | Reduced | -$49,251 | $600,108 | 0.01% |
45774W108 Insteel | Increased | $44,645 | $10.7M | 0.01% |
934423104 Warner Bros. Discovery | Increased | $9,600 | $97,771 | 0.00% |